PureTech Health (PRTC) Competitors GBX 162.60 +0.80 (+0.49%) (As of 11:45 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades PRTC vs. ONT, GNS, ERGO, SLN, OXB, HZD, VRP, BVXP, ARIX, and AVCTShould you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Oxford Nanopore Technologies (ONT), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Bioventix (BVXP), Arix Bioscience (ARIX), and Avacta Group (AVCT). These companies are all part of the "biotechnology" industry. PureTech Health vs. Oxford Nanopore Technologies Genus Ergomed Silence Therapeutics Oxford Biomedica Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Bioventix Arix Bioscience Avacta Group PureTech Health (LON:PRTC) and Oxford Nanopore Technologies (LON:ONT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations, community ranking and risk. Does the media refer more to PRTC or ONT? In the previous week, Oxford Nanopore Technologies' average media sentiment score of 1.21 beat PureTech Health's score of 0.00 indicating that Oxford Nanopore Technologies is being referred to more favorably in the news media. Company Overall Sentiment PureTech Health Neutral Oxford Nanopore Technologies Positive Does the MarketBeat Community prefer PRTC or ONT? PureTech Health received 497 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 86.58% of users gave PureTech Health an outperform vote. CompanyUnderperformOutperformPureTech HealthOutperform Votes52986.58% Underperform Votes8213.42%Oxford Nanopore TechnologiesOutperform Votes32100.00% Underperform VotesNo Votes Is PRTC or ONT more profitable? PureTech Health has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. PureTech Health's return on equity of -22.07% beat Oxford Nanopore Technologies' return on equity.Company Net Margins Return on Equity Return on Assets PureTech HealthN/A -22.07% -13.39% Oxford Nanopore Technologies -94.82%-26.08%-14.42% Do institutionals and insiders hold more shares of PRTC or ONT? 79.9% of PureTech Health shares are owned by institutional investors. Comparatively, 38.4% of Oxford Nanopore Technologies shares are owned by institutional investors. 15.9% of PureTech Health shares are owned by insiders. Comparatively, 32.6% of Oxford Nanopore Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has higher earnings and valuation, PRTC or ONT? PureTech Health has higher earnings, but lower revenue than Oxford Nanopore Technologies. PureTech Health is trading at a lower price-to-earnings ratio than Oxford Nanopore Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPureTech Health£3.33M116.33-£82.47M-£0.23-703.48Oxford Nanopore Technologies£167.75M6.82-£159.06M-£0.20-607.50 Which has more risk and volatility, PRTC or ONT? PureTech Health has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Oxford Nanopore Technologies has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Do analysts recommend PRTC or ONT? Oxford Nanopore Technologies has a consensus price target of GBX 235.50, indicating a potential upside of 93.83%. Given Oxford Nanopore Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Oxford Nanopore Technologies is more favorable than PureTech Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureTech Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Oxford Nanopore Technologies 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryOxford Nanopore Technologies beats PureTech Health on 9 of the 17 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTC vs. The Competition Export to ExcelMetricPureTech HealthBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£387.38M£164.71M£5.05B£1.38BDividend YieldN/A3.25%4.97%11.73%P/E Ratio-703.48329.4797.341,551.35Price / Sales116.3314,857.981,218.42209,189.85Price / Cash2.1411.6733.5132.93Price / Book1.237.115.802.80Net Income-£82.47M-£18.52M£119.07M£152.70M7 Day Performance-6.80%-0.25%-1.83%-0.54%1 Month Performance4.52%8.08%-3.64%7.07%1 Year Performance-1.34%25.99%31.62%91.74% PureTech Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTCPureTech HealthN/AGBX 162.60+0.5%N/A-5.6%£389.30M£3.33M-706.96300High Trading VolumeONTOxford Nanopore Technologies2.6671 of 5 starsGBX 124+1.3%GBX 235.50+89.9%-38.5%£1.17B£167.75M-612.001,281News CoveragePositive NewsHigh Trading VolumeGNSGenus2.1452 of 5 starsGBX 1,646-2.4%GBX 2,150+30.6%-24.0%£1.08B£668.80M14,050.00480High Trading VolumeERGOErgomedN/AGBX 1,346flatN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100High Trading VolumeOXBOxford Biomedica0.9962 of 5 starsGBX 413.50+0.2%GBX 433.33+4.8%+113.7%£435.66M£97.28M-287.15891Gap DownHigh Trading VolumeHZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/A+0.0%£228MN/A-1.6822Gap UpBVXPBioventixN/AGBX 3,746-0.1%N/A-5.2%£195.54M£13.60M2,298.1612ARIXArix BioscienceN/AGBX 142flatN/A+29.1%£183.73M£14.16M1,290.919AVCTAvacta GroupN/AGBX 46.90+6.0%N/A-67.2%£168.04M£22.62M-532.33120News CoveragePositive News Related Companies and Tools Related Companies ONT Competitors GNS Competitors ERGO Competitors SLN Competitors OXB Competitors HZD Competitors VRP Competitors BVXP Competitors ARIX Competitors AVCT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:PRTC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
